AstraZeneca (AZN) volatility elevated into shares selling off on failed drug trial
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Join SI Premium – FREE
AstraZeneca (NYSE: AZN) July call option implied volatility is at 100, August is at 53; compared to its 52-week range of 20 to 57 into a failed drug trial.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
- SentinelOne, Inc. (S) call put ratio 3.9 calls to 1 put with a focus on July 15 and 16 calls as share price up 3.4%
- SPS Commerce (SPSC) 400 contracts of July 60 calls trade
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
